Comparison of Bupivacaine alone and Bupivacaine with Dexmedetomidine as an adjuvant for spinal anaesthesia
Not Applicable
- Conditions
- Health Condition 1: S82- Fracture of lower leg, including ankleHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2022/02/040603
- Lead Sponsor
- Madhavan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
American Society of Anesthesiologists (ASA) grade I or II, weighing between 40-80 kg, scheduled to undergo elective lower limb orthopedic surgeries, under spinal anaesthesia in supine position.
Exclusion Criteria
Any patient with contraindications to spinal anaesthesia, known or ascertained hypersensitivity to local anesthetics (medications used in the trial), Patients on Betablocker antihypertensives with heart rate less than 60, coagulopathies, infection at the local site of injection, history of neurological/psychiatric diseases, any spinal deformity and patient refusal.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the duration of post-operative analgesia of bupivacaine alone with dexmedetomidine used as an adjuvant to the same dose of bupivacaine in spinal anaesthesia for lower limb orthopedic surgeries.Timepoint: Post operative VAS scores will be recorded for every 1 hour for 1st 4 hours, every 2hours for the next 6hrs and then every 4th hourly till 24 hours.
- Secondary Outcome Measures
Name Time Method Onset time of sensory block to T10 <br/ ><br>Time for 2 segment regression <br/ ><br>Hemodynamic parameters <br/ ><br>Duration of sensory block <br/ ><br>Duration of motor block. <br/ ><br>Timepoint: 24 hours